One tech company that had had a considerable impact in the past decade is mRNA therapeutics pioneer BioNTech SE (NASDAQ: BNTX). The mRNA technology has been instrumental in developing the COVID-19 vaccine, which the company developed in collaboration with Pfizer Inc. (NYSE: PFE).
BioNTech to develop a malaria vaccine
At the back of the successful devolvement of COVID-19 vaccines, BioNTech CEO and co-founder Ugur Sahin want to develop more mRNA-based vaccine. Recently the company announced that it would create an mRNA malaria vaccine with a range of treatments in its pipeline targeting various cancers. Equally, there are plans to address tuberculosis and HIV in the future.
Sahin, and Mayfield Fund Partner Ursheet Parikh, a significant investor in numerous up-and-coming biotechnology firms, will join the Disrupt 2021 this year. They will speak about the development of the COVID-19 vaccine, the future of mRNA technology, and the prospect of treating various chronic healthcare problems that have been difficult to solve for a long time. Equally, they will also discuss what it takes to create a biotech firm with realistic platform potential.
Reputable speakers to appear on the Disrupt Stage
The two are part of the many well-known speakers who will take the Disrupt stage and Extra Crunch Stage. For the three days the event will occur, Houseplant co-founder and CEO Michael Mohr, and Haneen Davies, Hosuplenat Chief Commercial Officer will join director, actor, writer, and Houseplant co-founder Seth Rogen to discuss the business of weed. Pete Buttigieg, Secretary of Transportation, will discuss the future of getting around and the role of government in partnering with startups. Finally, Coinbase CEO Brian Armstrong will delve into the volatile space of crypto and the exchange’s massive public listing at the start of the year.
Startup Battlefield, which is the competition that unveiled the world’s largest tech companies, including Dropbox and Cloudflare, will sum up Disrupt 2021
